New study validates clustering of QLQ-30 HRQoL scales, which can help symptom burden management and inform clinical trial design
27 May 2022
EORTC QLG Executive Committee – Call for Candidates
18 Mar 2022
EORTC Quality of Life Group Open Access Policy
15 Mar 2022
New QLG publication “Developing an e-learning course on the use of PRO measures in oncological practice: health care professionals’ preferences for learning content and methods”
24 Nov 2021
“Psychometric validation of the European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)”
28 Jul 2021
“Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors”
17 May 2021
“Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial”
14 May 2021
“Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients”
22 Oct 2020
